Outpatient-based therapy of oral fludarabine and subcutaneous alemtuzumab for asian patients with relapsed/refractory chronic lymphocytic leukemia
10.1155/2009/547582
Saved in:
Main Authors: | Hwang, W.Y.K., Dearden, C., Loh, Y.S.M., Linn, Y.C., Tien, S.L., Teoh, G.K.H., How, G.F., Heng, K.K., Goh, Y.T., Lee, L.H. |
---|---|
Other Authors: | DUKE-NUS GRADUATE MEDICAL SCHOOL S'PORE |
Format: | Article |
Published: |
2016
|
Online Access: | http://scholarbank.nus.edu.sg/handle/10635/129913 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Institution: | National University of Singapore |
Similar Items
-
Therapy-related myelodysplastic syndrome/acute myeloid leukemia following fludarabine therapy for non-Hodgkin lymphoma and chronic lymphocytic leukemia in Thai patients
by: Pimjai Niparuck, et al.
Published: (2018) -
Sequential administration of methotrexate and asparaginase in relapsed or refractory pediatric acute myeloid leukemia
by: Jassada Buaboonnam, et al.
Published: (2018) -
Carfilzomib-Dexamethasone vs Subcutaneous or Intravenous Bortezomib in Relapsed or Refractory Multiple Myeloma: Secondary Analysis of Phase 3 ENDEAVOR Study
by: Hartmut Goldschmidt, et al.
Published: (2018) -
Effect of anti-CD52 antibody alemtuzumab on ex-vivo culture of umbilical cord blood stem cells
by: Lim, C.K., et al.
Published: (2016) -
Mutational profiling of acute lymphoblastic leukemia with testicular relapse
by: Ding, L.-W, et al.
Published: (2020)